02/27/2026
NANS continues its advocacy efforts regarding peripheral nerve stimulation (PNS) coverage policy.
In response to recent payer determinations, the Society submitted formal comments urging alignment with current clinical evidence and established standards of care. Protecting appropriate patient access to neuromodulation therapies remains a top priority.
Read more: https://ow.ly/nKyq50Yni5U